Clinical trial
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating…
NCT00080990 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00080990 |
|---|---|
| Title | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors |
| Official title | An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Oxaliplatin and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | alvocidib, fluorouracil, oxaliplatin, leucovorin calcium |
| Enrollment | 46 |
| Start date | Feb 1, 2004 |
| Primary completion | Apr 1, 2009 |
| First posted | Apr 8, 2004 |
| Last update posted | Dec 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: